IBM Corp. announced that it will acquire Truven Analytics in a deal valued at $2.6 billion. IBM said Truven will bring more than 8,500 clients from government, employers, payers health systems and others to its IBM Watson Health unit.
“Most of the data in health-care is in disparate databases,” Deborah DiSanzo, General Manager at IBM Watson Health, told Bloomberg. “The strategy of IBM is to bring this data together and democratize it so that both IBM and our ecosystem of partners can build health solutions on top of it.”
In an interview with Fortune, DiSanzo pointed to the real value of Truven: IBM gets “200 million lives which we can combine with 100 million patient records. We can combine our data sets together, including one of the largest democratized health records with electronic health records from Phytel, Truven, claims data, imaging data, genetics, medical health data and from all of that we can run analysis.”